The Role of IL-1 in Rat Carrageenan Pleurisy
Author Information
Author(s): R. Goodman, L. R. Mantegna, C. L. McAllister, E. Bruin, R. L. Dowling, H. George, W. Feeser, B. Freimark, M. Lischwe, S. Pick, R. R. Harris, J. S. Kerr
Primary Institution: The DuPont Merck Pharmaceutical Company
Hypothesis
What is the role of IL-1 in the inflammatory response in the carrageenan pleurisy model?
Conclusion
IL-1 is not the initiator of the pro-inflammatory events in the carrageenan pleurisy model, despite its levels increasing in response to carrageenan.
Supporting Evidence
- IL-1 levels increased significantly in the pleural cavity after carrageenan injection.
- Cell influx increased 13-fold from 30 minutes to 4 hours post-injection.
- Fluid extravasation significantly increased in carrageenan treated animals compared to saline controls.
- None of the tested anti-inflammatory drugs maintained cell influx and IL-1 levels at control levels.
- Fasting affected the variability of plasma corticosterone levels in response to carrageenan.
Takeaway
This study looked at how a substance called IL-1 affects inflammation in rats. It found that while IL-1 levels go up during inflammation, it doesn't actually start the inflammation process.
Methodology
Male Lewis rats were injected with carrageenan or saline, and various measurements were taken to assess cell counts, fluid volumes, and IL-1 levels.
Limitations
The study was conducted on a specific strain of rats, which may limit the generalizability of the findings.
Participant Demographics
Male Lewis rats weighing 200-250 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website